Mono Clonal Spike

Lab Reagents

Human IgG antibody Laboratories manufactures the mono clonal spike reagents distributed by Genprice. The Mono Clonal Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Monoclonal. Other Mono products are available in stock. Specificity: Mono Category: Clonal Group: Spike

Spike information

(PEO)4-mono-amine
20-abx180932	Abbexa	EUR 1412.40 EUR 410.40 EUR 961.20	10 g 1 g 5 g

mono-tert-Butyl malonate
20-abx182580	Abbexa	EUR 543.60 EUR 326.40 EUR 260.40	100 g 25 g 5 g

mono-(BOC)-ethylene diamine
20-abx184234	Abbexa	EUR 326.40 EUR 243.60 EUR 777.60	100 g 25 g 500 g

Mono/Poly-Ubiquitin Antibody
abx415342-50ug	Abbexa	50 ug	EUR 678

Mono Q 10 100Gml
17516701	Scientific Laboratory Supplies	EACH	EUR 9607.92

Mono S 10 100Gml
17516901	Scientific Laboratory Supplies	EACH	EUR 9607.92

CY3 MONO 5-PACK
GEPA23001	Scientific Laboratory Supplies	PK5	EUR 305.52

CY5 MONO 5-PACK
GEPA25001	Scientific Laboratory Supplies	EACH	EUR 305.52

Mettler Inlab Mono Probe
PHE0344	Scientific Laboratory Supplies	EACH	EUR 136.23

JACK ADAPTOR ANALOG/MONO
ZFREAC001	Scientific Laboratory Supplies	EACH	EUR 90.06

SARS-CoV Spike Antibody
3219-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS (IN1) Spike Peptide
3221P	ProSci	0.05 mg	EUR 197.7
Description: (IN) SARS (IN1) Spike peptide

SARS-CoV Spike Antibody
3223-002mg	ProSci	0.02 mg	EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-01mg	ProSci	0.1 mg	EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.